Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: Diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy

Respirology

Volumn 6, Issue 4, 2001, Pages 331-340

  Seyama, Kuniaki ^a   Kira, Shiro ^a   Takahashi, Hideki ^a   Ohnishi, Masahiro ^a   Kodama, Yuzo ^a   Dambara, Takashi ^a   Kobayashi, June ^b   Kitamura, Satoshi ^b   Fukuchi, Yoshinosuke ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti hormone therapy; Diffusing capacity; Obstructive ventilatory impairment; Pulmonary lymphangioleiomyomatosis

Indexed keywords

GONADORELIN DERIVATIVE; HORMONE ANTAGONIST; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG INDICATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HORMONAL THERAPY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; PATIENT MONITORING; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; VITAL CAPACITY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; FOLLOW-UP STUDIES; HORMONE ANTAGONISTS; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; LYMPHANGIOLEIOMYOMATOSIS; MEDROXYPROGESTERONE 17-ACETATE; OVARIECTOMY; RETROSPECTIVE STUDIES; TAMOXIFEN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035698374     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2001.00343.x     Document Type: Article

References (33)

1. Diffuse lung disease due to lymphangiomyoma
2. Lymphangiomyomatosis: Clinico-anatomical entity
3. Pulmonary lymphangiomyomatosis
4. Pulmonary lymphangiomyomatosis: A review
5. Lymphangioleiomyomatosis: Physiologic-pathologic-radiologic correlations
6. Lymphangioleiomyomatosis: Clinical course in 32 patients
7. Pulmonary lymphangioleiomyomatosis: A report of 46 patients including a clinicopathologic study of prognostic factors
8. Pulmonary lymphangiomyomatosis
9. Pulmonary lymphangiomyomatosis responsive to progesterone
10. Pulmonary lymphangiomyomatosis complicated by pregnancy
11. Efficiency of oophorectomy in lymphangio-leiomyomatosis and benign metastasizing leiomyoma
12. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens
13. Pulmonary lymphangioleiomyomatosis: A case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen
14. Pulmonary lymphangiomyomatosis with particular reference to steroid-receptor assay studies and pathologic correlation
15. Pulmonary lymphangiomyomatosis
16. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone
17. Pulmonary lymphangiomyomatosis: Long-term survival in a patient with poor response to medroxyprogesterone
18. A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy
19. Pulmonary lymphangiomyomatosis: Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases
20. Lymphangiomyomatosis: A report of three cases treated with tamoxifen
21. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis
22. Pulmonary lymphangiomyomatosis: Treatment with castration
23. Treatment of lymphangio-leiomyomatosis: A meta-analysis
24. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria
25. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis?
26. Manifestations of respiratory disease
27. Computerized tomography in the diagnosis of lymphangioleiomyomatosis
28. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings
29. Pulmonary lymphangio-leiomyomatosis: Prolonged survival despite multiple pregnancies and no hormonal intervention
30. Pulmonary lymphangio-leiomyomatosis: Quantitative analysis of lesions producing airflow limitation
31. Pulmonary mechanics in lymphangioleiomyomatosis
32. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
33. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs